Get caught up quickly on the top news and calls moving stocks with these Top Fives, as compiled by the editors of The Fly.

1. STOCK NEWS:

• Nike (NKE) reported upbeat Q2 results and reiterated its FY22 revenue guidance [more]
• Boeing (BA) announced a purchase order for 19 767 Freighters from UPS (UPS) [more]
• AT&T (T) will sell its advertising marketplace Xandr to Microsoft (MSFT) [more]
• MasterCard (MA) will acquire McDonald's (MCD) personalization platform Dynamic Yield [more]
• Sanofi (SNY) will acquire Amunix Pharmacueticals for $1B upfront, up to $225M more [more]

2. WALL STREET CALLS:

• Micron (MU) upgraded to Buy at BofA on improved "inventory digestion" outlook [more]
• Atlantic Equities downgrades Alibaba (BABA) to Neutral, cuts target to $140 [more]
• KeyBanc downgrades Oracle (ORCL), calls Cerner (CERN) deal non-strategic [more]
• KLA Corp. (KLAC) upgraded to Overweight from Equal Weight at Wells Fargo [more]
• ResMed (RMD) upgraded to Overweight on recurring revenue growth at KeyBanc [more]

3. AROUND THE WEB:

• The FDA could authorize COVID-19 treatment pills from Merck (MRK) and Pfizer (PFE) this week, Bloomberg reports [more]
• Elliott and Vista are weighing a joint bid for Citrix Systems (CTXS), Bloomberg reports [more]
• Foxconn's (HNHPF) southern India plant will remain shut down for the week, Reuters says [more]
• Presidio in discussions to acquire Exxon Mobil (XOM) shale gas wells, Reuters says [more]
• Intel (INTC) delayed yet another product, SemiAccurate reports [more]

4. MOVERS:

• Cassava Sciences (SAVA) surges after it said that Neuroscience found no evidence of data manipulation [more]
• Nikola (NKLA) rises after announcing a resolution with the U.S. SEC in which the company has agreed to pay $125M [more]
• Apogee Enterprises (APOG) higher after reporting quarterly results [more]
• Aquestive Therapeutics (AQST) falls after the FDA said it is still considering the regulatory issues related to the approvability of Libervant, and will not be ready to take an action by December 23 [more]
• Aldeyra (ALDX) drops after announcing the Phase 3 TRANQUILITY Trial of 0.25% reproxalap ophthalmic solution did not hit its primary endpoint [more]

5. EARNINGS/GUIDANCE:

• Micron (MU) reported upbeat quarterly earnings and revenue [more]
• Rite Aid (RAD) raised its FY22 earnings guidance [more]
• General Mills (GIS) reported mixed results for Q2 [more]
• Enerpac Tool (EPAC) reported downbeat Q1 earnings and revenue [more]
• FactSet (FDS) reported upbeat Q1 results [more]

INDEXES:

The Dow rose 560.54, or 1.6%, to 35,492.70, the Nasdaq gained 360.14 or 2.4%, to 15,341.09, and the S&P 500 advanced 81.21, or 1.78%, to 4,649.23.